
NAD+ plays a crucial role in cellular energy metabolism and regulation of oxidative stress. Declines in NAD+ levels are linked to cardiometabolic diseases. NAD-based therapies show promise in preclinical studies for treating heart failure, yet mechanisms are not fully understood, and clinical translation remains challenging. This review explores the latest literature on NAD+ interventions and their potential in heart disease treatment.
Like
Save
Share